Sun Biomedical Ltd (SBN.AX)

SBN.AX on Australia Stock Exchange

26 Mar 2015
Change (% chg)

$-0.00 (-11.11%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for SBN.AX


Sun Biomedical Limited is an international biotechnology company engaged in the commercialization of improved versions of its Oraline hand held multi drug test device and looking to increase its biotechnology investments. Its other product include VisuaLine multi dip panel (In development), which is used to test illicit drugs... (more)
No analyst recommendations are available for SBN.AX.


Beta: 1.43
Market Cap(Mil.): $3.72
Shares Outstanding(Mil.): 413.64
Dividend: --
Yield (%): --


  SBN.AX Industry Sector
P/E (TTM): -- 41.29 40.89
EPS (TTM): -0.00 -- --
ROI: -35.05 10.74 16.10
ROE: -35.05 12.55 16.95
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: GlobalData
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks